pyrazolospirocetones inhibitory N1-acetyl-coa carboxylase

The invention relates to a compound of formula (I) or a pharmaceutically acceptable salt of the compound, wherein R1, R2, R3 and R4 are as described herein; pharmaceutical compositions thereof; and the use thereof in the treatment of diseases, conditions or disorders modulated by the inhibition of one or more enzyme (s) acetyl-CoA carboxylase (s) in an animal.